Analysts at a trio of investment advisory firms downgraded their estimates for C.R. Bard (NYSE:BCR) stock, which hasn’t fared well recently.
Analysts bearish on C.R. Bard
Morgan Keenan
Continue to Site
The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Analysts at a trio of investment advisory firms downgraded their estimates for C.R. Bard (NYSE:BCR) stock, which hasn’t fared well recently.
